GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.18 $2.79 Tuesday, 16th Apr 2024 FGEN stock ended at $1.30. This is 0.763% less than the trading day before Monday, 15th Apr 2024. During the day the stock fluctuated 8.00% from a day low at $1.25 to a day high of $1.35.
90 days $0.735 $2.93
52 weeks $0.335 $20.90

Historical FibroGen prices

Date Open High Low Close Volume
2024-04-16 $1.28 $1.35 $1.25 $1.30 844 014
2024-04-15 $1.30 $1.37 $1.24 $1.31 1 232 018
2024-04-12 $1.35 $1.35 $1.23 $1.30 1 132 619
2024-04-11 $1.45 $1.47 $1.35 $1.36 942 162
2024-04-10 $1.49 $1.51 $1.37 $1.43 1 350 895
2024-04-09 $1.62 $1.63 $1.49 $1.51 1 011 650
2024-04-08 $1.63 $1.69 $1.56 $1.63 1 084 047
2024-04-05 $1.56 $1.70 $1.51 $1.62 1 614 115
2024-04-04 $1.41 $1.82 $1.39 $1.58 4 157 493
2024-04-03 $2.14 $2.14 $1.18 $1.47 10 311 482
2024-04-02 $2.28 $2.33 $2.10 $2.16 894 815
2024-04-01 $2.35 $2.40 $2.17 $2.36 1 275 625
2024-03-28 $2.58 $2.59 $2.31 $2.35 1 354 382
2024-03-27 $2.46 $2.68 $2.30 $2.58 1 845 399
2024-03-26 $2.67 $2.79 $2.41 $2.44 1 529 885
2024-03-25 $2.59 $2.79 $2.55 $2.64 1 606 281
2024-03-22 $2.43 $2.66 $2.37 $2.58 1 552 640
2024-03-21 $2.37 $2.49 $2.32 $2.43 1 036 542
2024-03-20 $2.34 $2.39 $2.16 $2.36 1 507 685
2024-03-19 $2.15 $2.40 $2.15 $2.35 1 260 774
2024-03-18 $2.17 $2.36 $1.95 $2.17 2 516 183
2024-03-15 $2.09 $2.20 $2.01 $2.09 1 893 376
2024-03-14 $2.04 $2.17 $1.92 $2.09 1 570 163
2024-03-13 $1.90 $2.18 $1.86 $2.00 3 059 212
2024-03-12 $1.80 $2.07 $1.76 $1.89 2 045 621
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT